Fibromyalgia Syndrome Clinical Trial
Official title:
Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome
NCT number | NCT05034770 |
Other study ID # | 2020-161 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 1, 2017 |
Est. completion date | January 11, 2022 |
Verified date | August 2022 |
Source | Kocaeli University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Patients who were admitted to the Physical Medicine and Rehabilitation (PMR) outpatient clinic of our hospital between January 2017 and December 2020 and were treated with Major ozone autohemotherapy with a diagnosis of Fibromyalgia syndrome will include to the study. Visual anolog scale (VAS), Fibromyalgia Impact Questionnare (FIQ) and Short Form Health Survey-36 (SF-36) scores of the patients before and after treatment were recorded. Statistical analysis of these outcome scores will be made.
Status | Completed |
Enrollment | 45 |
Est. completion date | January 11, 2022 |
Est. primary completion date | January 10, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Exclusion Criteria: - has pregnancy, - has primary romatological disease, - has primary psychiatric disease - <18, >60 years old patients |
Country | Name | City | State |
---|---|---|---|
Turkey | Private Medar Hospital | Kocaeli |
Lead Sponsor | Collaborator |
---|---|
Emine Dundar Ahi, MD |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Visual Analog Scale (VAS) | The Visual Analog Scale (VAS) is usually a 100-mm long horizontal line with verbal descriptors (word anchors) at each end to express the extremes of the feeling. FM patients mark the point on the line that best corresponds to their symptom severity. To this end, they are instructed to put a cross on the straight line at the point that most accurately expresses their degree of agreement. When reading the VAS, the position of the respondent's cross is generally assigned a score between 0 and 100. If documented in paper form, the scores can then be simply transferred to a 100-value scale using a millimeter tape measure. The division into hundredths is considered suf?ciently sensitive. | 10 seconds | |
Primary | Short Form Health Survey-36 | the 36-item Short Form Health Survey (SF-36) is a measure of health-related quality-of-life. It allows assessment across eight health domains: physical functioning (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH). The scores of these eight domains can also be summated in two major categories: physical composite score (PCS) and mental composite score (MCS) to reflect the overall physical and mental health, respectively. Scores of 100 for PF, RP, BP, SF, and RE domains and scores of 50 in the remaining three domains, GH, VT, and MH, indicate an absence of problems in those areas. | 20 minutes | |
Secondary | Fibromyalgia Impact Questionnare | The Fibromyalgia Impact Questionnare (FIQ) is an assessment and evaluation instrument developed to measure fibromyalgia (FM) patient status, progress and outcomes. It has been designed to measure the components of health status that are believed to be most affected by FM. FIQ is scored in such a way that a higher score indicates a greater impact of the syndrome on the person. Each of the 10 items has a maximum possible score of 10. Thus the maximum possible score is 100. The average FM patient scores about 50, severely afflicted patients are usually 70 plus. | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05933486 -
Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome
|
Phase 4 | |
Completed |
NCT01642810 -
Online Acceptance-based Behavioural Treatment for Fibromyalgia
|
Phase 3 | |
Completed |
NCT00757679 -
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
|
Phase 2 | |
Completed |
NCT00757731 -
FMS European Long-Term Study
|
Phase 3 | |
Completed |
NCT01968772 -
Effect of Transdermal Magnesium Chloride on Quality of Life in Patients With Fibromyalgia
|
N/A | |
Completed |
NCT00401830 -
Assessing Efficacy and Safety of Lacosamide Compared to Placebo in Reducing Signs and Symptoms of Fibromyalgia Syndrome.
|
Phase 2 | |
Completed |
NCT04517929 -
Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT06285045 -
Study on Roujin Formula in the Treatment of Fibromyalgia Syndrome With Blood Deficiency and Liver Depression
|
N/A | |
Completed |
NCT03844412 -
Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments
|
Phase 2 | |
Completed |
NCT02800720 -
Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome
|
N/A | |
Not yet recruiting |
NCT01465477 -
Influenza Vaccination in Fibromyalgia Patients
|
N/A | |
Completed |
NCT00528710 -
Efficacy of S-Adenosylmethionine in Fibromyalgia
|
Phase 2 | |
Completed |
NCT00447083 -
Benefits of Tanning in Fibromyalgia Patients
|
N/A | |
Not yet recruiting |
NCT06147882 -
The Effect of Positive Psychotherapy Based Psychoeducation on Pain Perception With Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT05381012 -
Fibromyalgia Syndrome on Patients With Chronic Migraine
|
N/A | |
Completed |
NCT00464737 -
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults.
|
Phase 2 | |
Completed |
NCT04426864 -
Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome.
|
N/A | |
Completed |
NCT02881411 -
Self Soft Tissue Therapy for Fibromyalgia Syndrome
|
N/A | |
Completed |
NCT01389336 -
Add-on Complex Ayurvedic Treatment in Fibromyalgia-Syndrome Compared to Standard Care Alone
|
N/A | |
Not yet recruiting |
NCT01147263 -
Palpitations and Tachycardia in Fibromyalgia Syndrome
|
N/A |